Literature DB >> 15271590

Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study.

Elizabeth A Young1, Naomi Breslau.   

Abstract

BACKGROUND: Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, so it was expected that posttraumatic stress disorder (PTSD) would be associated with activation of this axis; however, studies have found both increased and decreased cortisol in PTSD. To address this question, we collected saliva cortisol at home in a subsample of a longitudinal epidemiologic sample.
METHODS: Six hundred eighty-four persons randomly selected from the total sample of 913 were requested to collect saliva samples upon awakening and in the early evening. Of these, 538 responded with samples, 516 of whom met inclusion criteria. These were 68 exposed to trauma with lifetime PTSD, 265 exposed to trauma with no PTSD, and 183 never exposed to trauma.
RESULTS: In a comparison of these three groups, lifetime PTSD revealed elevated evening saliva cortisol compared with exposed/no PTSD. When lifetime comorbidity with major depressive disorder (MDD) was included in the analysis, only persons with comorbid PTSD and MDD showed this evening elevation in cortisol. Persons with PTSD alone (never MDD) showed normal saliva cortisol levels, as did subjects with lifetime MDD alone.
CONCLUSIONS: Neither exposure to trauma nor PTSD alone is associated with alterations in saliva cortisol; however, elevated cortisol is found in PTSD comorbid with lifetime MDD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271590     DOI: 10.1016/j.biopsych.2004.05.011

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  36 in total

1.  The aftermath of 9/11: effect of intensity and recency of trauma on outcome.

Authors:  Barbara Ganzel; B J Casey; Gary Glover; Henning U Voss; Elise Temple
Journal:  Emotion       Date:  2007-05

Review 2.  Childhood stressful events, HPA axis and anxiety disorders.

Authors:  Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca
Journal:  World J Psychiatry       Date:  2012-02-22

3.  Current challenges in female veterans' health.

Authors:  Eileen M Resnick; Monica Mallampalli; Christine L Carter
Journal:  J Womens Health (Larchmt)       Date:  2012-08-09       Impact factor: 2.681

4.  PTSD, comorbid depression, and the cortisol waking response in victims of intimate partner violence: preliminary evidence.

Authors:  Keri L M Pinna; Dawn M Johnson; Douglas L Delahanty
Journal:  Anxiety Stress Coping       Date:  2013-11-28

Review 5.  Stress and brain atrophy.

Authors:  J Douglas Bremner
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-10       Impact factor: 4.388

6.  Basal and suppressed salivary cortisol in female Vietnam nurse veterans with and without PTSD.

Authors:  Linda J Metzger; Margaret A Carson; Natasha B Lasko; Lynn A Paulus; Scott P Orr; Roger K Pitman; Rachel Yehuda
Journal:  Psychiatry Res       Date:  2008-10-25       Impact factor: 3.222

Review 7.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

8.  Salivary cortisol levels and mood vary by lifetime trauma exposure in a sample of healthy women.

Authors:  Barbara L Ganzel; John J Eckenrode; Pilyoung Kim; Elaine Wethington; Eric Horowitz; Elise Temple
Journal:  J Trauma Stress       Date:  2007-10

9.  The impact of maternal childhood abuse on maternal and infant HPA axis function in the postpartum period.

Authors:  Sarah R Brand; Patricia A Brennan; D Jeffrey Newport; Alicia K Smith; Tamara Weiss; Zachary N Stowe
Journal:  Psychoneuroendocrinology       Date:  2009-11-20       Impact factor: 4.905

10.  Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent.

Authors:  R N Carter; J M Paterson; U Tworowska; D J Stenvers; J J Mullins; J R Seckl; M C Holmes
Journal:  J Neuroendocrinol       Date:  2009-07-07       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.